Cargando…

The PK/PD Integration and Resistance of Tilmicosin against Mycoplasma hyopneumoniae

Mycoplasma hyopneumoniae is the major pathogen causing enzootic pneumonia in pigs. M. hyopneumoniae infection can lead to considerable economic losses in the pig-breeding industry. Here, this study established a first-order absorption, one-compartment model to study the relationship between the phar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Zilong, Hu, Zixuan, Zheng, Haorui, Xia, Xirui, Gu, Xiaoyan, Shen, Xiangguang, Yang, Hong, Ding, Huanzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350388/ https://www.ncbi.nlm.nih.gov/pubmed/32575357 http://dx.doi.org/10.3390/pathogens9060487

Ejemplares similares

Pharmacokinetic and Pharmacodynamic Integration and Resistance Analysis of Tilmicosin Against Mycoplasma gallisepticum in an In Vitro Dynamic Model
por: Huang, Zilong, et al.
Publicado: (2019)

Pharmacokinetic/Pharmacodynamic Integration of Doxycycline Against Mycoplasma hyopneumoniae in an In Vitro Model
por: Zhang, Huilin, et al.
Publicado: (2019)

Emergence and Mechanism of Resistance of Tulathromycin Against Mycoplasma hyopneumoniae in a PK/PD Model and the Fitness Costs of 23S rRNA Mutants
por: Xia, Xirui, et al.
Publicado: (2022)

The PK/PD Interactions of Doxycycline against Mycoplasma gallisepticum
por: Zhang, Nan, et al.
Publicado: (2016)

Determination of the Mutant Selection Window and Evaluation of the Killing of Mycoplasma gallisepticum by Danofloxacin, Doxycycline, Tilmicosin, Tylvalosin and Valnemulin
por: Zhang, Nan, et al.
Publicado: (2017)

Analysis of the mutant selection window and killing of Mycoplasma hyopneumoniae for doxycycline, tylosin, danofloxacin, tiamulin, and valnemulin
por: Huang, Zilong, et al.
Publicado: (2020)

The PK–PD Relationship and Resistance Development of Danofloxacin against Mycoplasma gallisepticum in An In Vivo Infection Model
por: Zhang, Nan, et al.
Publicado: (2017)

Relationship between danofloxacin PK/PD parameters and emergence and mechanism of resistance of Mycoplasma gallisepticum in In Vitro model
por: Zhang, Nan, et al.
Publicado: (2018)

Chemotherapeutic Strategies with Valnemulin, Tilmicosin, and Tulathromycin to Control Mycoplasma hyopneumoniae Infection in Pigs
por: Stingelin, Giovani Marco, et al.
Publicado: (2022)

Pharmacokinetic and Pharmacodynamic integration of tilmicosin against Mycoplasma gallisepticum in the target infection site in chickens
por: Zhang, Nan, et al.
Publicado: (2022)

Pharmacokinetic/pharmacodynamic integration of tilmicosin against Pasteurella multocida in a piglet tissue cage model
por: Chen, Yuqin, et al.
Publicado: (2023)

PK/PD integration of florfenicol alone and in combination with doxycycline against Riemerella anatipestifer
por: Zhang, Huilin, et al.
Publicado: (2022)

Correlation of PK/PD Indices with Resistance Selection for Cefquinome against Staphylococcus aureus in an In Vitro Model
por: Li, Yafei, et al.
Publicado: (2016)

Kill Rate and Evaluation of Ex Vivo PK/PD Integration of Cefquinome Against Actinobacillus pleuropneumoniae
por: Zhang, Longfei, et al.
Publicado: (2021)

Pathogenicity & virulence of Mycoplasma hyopneumoniae
por: Leal Zimmer, Fernanda M. A., et al.
Publicado: (2020)

Murine Thigh Microdialysis to Evaluate the Pharmacokinetic/Pharmacodynamic Integration of Cefquinome Against Actinobacillus pleuropneumoniae
por: Zhang, Longfei, et al.
Publicado: (2020)

PK-PD integration of enrofloxacin and cefquinome alone and in combination against Klebsiella pneumoniae using an in vitro dynamic model
por: Wei, Yanzhe, et al.
Publicado: (2023)

Intrinsic terminators in Mycoplasma hyopneumoniae transcription
por: Fritsch, Tiago Ebert, et al.
Publicado: (2015)

Selective medium for culture of Mycoplasma hyopneumoniae
por: Cook, Beth S., et al.
Publicado: (2016)

Control of Mycoplasma hyopneumoniae infections in pigs
por: Maes, D., et al.
Publicado: (2008)

Pharmacokinetic/Pharmacodynamic Integration to Evaluate the Changes in Susceptibility of Actinobacillus pleuropneumoniae After Repeated Administration of Danofloxacin
por: Zhang, Longfei, et al.
Publicado: (2018)

In vitro protective efficacy of Lithium chloride against Mycoplasma hyopneumoniae infection
por: Ishag, Hassan Z.A., et al.
Publicado: (2016)

Repetitive Elements in Mycoplasma hyopneumoniae Transcriptional Regulation
por: Cattani, Amanda Malvessi, et al.
Publicado: (2016)

Extracellular Actin Is a Receptor for Mycoplasma hyopneumoniae
por: Raymond, Benjamin B. A., et al.
Publicado: (2018)

Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs
por: Maes, Dominiek, et al.
Publicado: (2021)

Porcine antibody profiles of 33 Mycoplasma hyopneumoniae fusion proteins from M. hyopneumoniae natural infection but not vaccination
por: Ning, Yaru, et al.
Publicado: (2022)

Microdialysis Determination of Cefquinome Pharmacokinetics in Murine Thigh From Healthy, Neutropenic, and Actinobacillus pleuropneumoniae-Infected Mice
por: Zhang, Longfei, et al.
Publicado: (2019)

A field evaluation of two vaccines against Mycoplasma hyopneumoniae infection in pigs
por: Kristensen, Charlotte S, et al.
Publicado: (2014)

Efficacy of three innovative bacterin vaccines against experimental infection with Mycoplasma hyopneumoniae
por: Matthijs, Anneleen Marguerite Filip, et al.
Publicado: (2019)

Efficacy of a novel bivalent vaccine containing porcine circovirus type 2d and Mycoplasma hyopneumoniae against a dual PCV2d and Mycoplasma hyopneumoniae challenge
por: Ham, Sehyeong, et al.
Publicado: (2023)

Proteogenomic mapping of Mycoplasma hyopneumoniae virulent strain 232
por: Pendarvis, Ken, et al.
Publicado: (2014)

MLVA typing of Mycoplasma hyopneumoniae bacterins and field strains
por: Tamiozzo, P., et al.
Publicado: (2015)

Survey on Mycoplasma hyopneumoniae gilt acclimation practices in Europe
por: Garza-Moreno, Laura, et al.
Publicado: (2017)

Current perspectives on the diagnosis and epidemiology of Mycoplasma hyopneumoniae infection
por: Sibila, Marina, et al.
Publicado: (2009)

Influence of pig gut microbiota on Mycoplasma hyopneumoniae susceptibility
por: Surendran Nair, Meera, et al.
Publicado: (2019)

Construction of Mycoplasma hyopneumoniae P97 Null Mutants
por: Clampitt, Jeannett M., et al.
Publicado: (2021)

Genotyping and biofilm formation of Mycoplasma hyopneumoniae and their association with virulence
por: Wu, Yuzi, et al.
Publicado: (2022)

Relationship between Cefquinome PK/PD Parameters and Emergence of Resistance of Staphylococcus aureus in Rabbit Tissue-Cage Infection Model
por: Xiong, Mingpeng, et al.
Publicado: (2016)

Transcriptomic investigation reveals toxic damage due to tilmicosin and potential resistance against tilmicosin in primary chicken myocardial cells
por: Zhang, Xiaohui, et al.
Publicado: (2020)

Efficacy of Mycoplasma hyopneumoniae vaccination before and at weaning against experimental challenge infection in pigs
por: Arsenakis, Ioannis, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kvmgcjoc0tp8b986kq3o8et3lv